SpinChip Diagnostics AS Revenue and Competitors

Oslo, Norway

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SpinChip Diagnostics AS's estimated annual revenue is currently $7.7M per year.(i)
  • SpinChip Diagnostics AS's estimated revenue per employee is $126,000

Employee Data

  • SpinChip Diagnostics AS has 61 Employees.(i)
  • SpinChip Diagnostics AS grew their employee count by 7% last year.

SpinChip Diagnostics AS's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.2M225%N/AN/A
#2
$25.7M167-52%N/AN/A
#3
$7.7M617%N/AN/A
#4
$7.4M59-6%N/AN/A
#5
$22M143N/AN/AN/A
#6
$3.4M300%N/AN/A
#7
$14.4M1036%N/AN/A
#8
$41.7M271-13%N/AN/A
#9
$2.5M268%N/AN/A
#10
$4.7M422%N/AN/A
Add Company

What Is SpinChip Diagnostics AS?

SpinChip Diagnostics is a medical device company who is developing a game changing and proprietary platform for in vitro diagnostics point of care analyses. The platform will make it possible to perform a broader range of analyses using one platform and to transfer analyses from central laboratories to point of care without loss in quality. All analyses are performed within a few minutes based on a fraction of a droplet of blood and at a unit cost significantly lower than other point of care platforms.

keywords:N/A

N/A

Total Funding

61

Number of Employees

$7.7M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SpinChip Diagnostics AS News

2022-04-17 - (post-pandemic Scenario) Haematology Analyzers Market Poised ...

Roche Diagnostics International • SigTuple Technologies Private Limited • SpinChip Diagnostics AS • Sysmex • T2. Biosystems • Tarabios

2022-04-17 - Haematology Analyzers Market Size, Outlook And Forecast ...

... Mindray Medical International, Noninvasix, Quotient, Roche Diagnostics International, SigTuple Technologies Private, SpinChip Diagnostics, Sysmex, T2.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A6124%N/A
#2
$11.1M61-27%N/A
#3
$12.1M6130%N/A
#4
$8M6120%N/A
#5
$8.1M62-3%N/A